Researchers in Japan have developed a vaccination strategy in mice that promotes the production of antibodies that can neutralize not only SARS-CoV-2 but a broad range of other coronaviruses as well. If successfully translated ...
Oct 8, 2021
0
119
As Australia strives to reach its national COVID vaccination targets, there's unprecedented focus on the biological effects of vaccines.
Oct 8, 2021
0
10
As SARS-CoV-2 continues to evolve, new variants are expected to arise that may have an increased ability to infect their hosts and evade the hosts' immune systems. The first key step in infection is when the virus's spike ...
Sep 29, 2021
0
138
Scientists at La Jolla Institute for Immunology (LJI) have published a detailed map of where human antibodies bind to SARS-CoV-2, a map that was generated by a global collaboration comparing nearly all leading clinical candidates. ...
Sep 23, 2021
0
320
People infected with the original strain of the virus that causes COVID-19 early in the pandemic produced a consistent antibody response, making two main groups of antibodies to bind to the spike protein on the virus's outer ...
Sep 20, 2021
1
278
A group of researchers at Université de Montréal has simulated the effects of more than 17,000 possible mutations of the spike protein of SARS-CoV-2, the virus responsible for COVID-19.
Sep 17, 2021
0
7
The Delta variant of SARS-CoV-2, which has become the dominant variant in countries including India and the UK, has most likely spread through its ability to evade neutralizing antibodies and its increased infectivity, say ...
Sep 6, 2021
0
618
Around 20% of those who have recovered from COVID-19 fail to develop immune protection against SARS-CoV-2, according to a MedUni Vienna research team led by allergist and immunologist Rudolf Valenta from the Center for Pathophysiology, ...
Aug 30, 2021
0
316
Let the record show that the current COVID-19 vaccines work, and they work well. But what is the next step in vaccine development, especially amid increasing rates of breakthrough infections and emergence of variants of concern?
Aug 18, 2021
0
832
A Johns Hopkins Medicine research team has shown that people living with the human immunodeficiency virus (HIV) are likely to be protected against SARS-CoV-2, the virus that causes COVID-19, if they are fully vaccinated.
Aug 11, 2021
0
202
